Is Protean eGov overvalued or undervalued?
As of November 10, 2025, Protean eGov is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 37.47 and poor stock performance, contrasting sharply with its peers TCS and Infosys, which are rated attractive and fairly valued, respectively.
As of 10 November 2025, the valuation grade for Protean eGov has moved from very expensive to expensive, indicating a shift in perceived value. The company is currently considered overvalued based on its financial metrics. Key ratios include a PE ratio of 37.47, an EV to EBITDA of 18.14, and a PEG ratio of 4.44, which suggest that the stock is priced significantly higher than its earnings growth potential.In comparison to its peers, TCS is rated attractive with a PE of 21.77 and EV to EBITDA of 8.55, while Infosys is fairly valued with a PE of 22.37. This stark difference highlights the premium at which Protean eGov is trading relative to more established competitors. Additionally, the company's recent stock performance has been poor, with a year-to-date return of -56.6%, contrasting sharply with the Sensex's gain of 6.91% in the same period, further reinforcing the notion that Protean eGov is overvalued.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
